{"id":"https://openalex.org/W76302322","doi":"https://doi.org/10.33588/rn.4210.2005252","title":"Neuroprotecci\u00f3n con memantina (antagonista no competitivo del receptor NMDA-glutamato) frente a la excitotoxicidad asociada al glutamato en la enfermedad de Alzheimer y en la demencia vascular","display_name":"Neuroprotecci\u00f3n con memantina (antagonista no competitivo del receptor NMDA-glutamato) frente a la excitotoxicidad asociada al glutamato en la enfermedad de Alzheimer y en la demencia vascular","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W76302322","doi":"https://doi.org/10.33588/rn.4210.2005252","mag":"76302322","pmid":"https://pubmed.ncbi.nlm.nih.gov/16703529"},"language":"es","primary_location":{"id":"doi:10.33588/rn.4210.2005252","doi":"https://doi.org/10.33588/rn.4210.2005252","is_oa":false,"landing_page_url":"https://doi.org/10.33588/rn.4210.2005252","pdf_url":null,"source":{"id":"https://openalex.org/S184263677","display_name":"Revista de Neurolog\u00eda","issn_l":"0210-0010","issn":["0210-0010","1576-6578"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4322632785","host_organization_name":"Viguera Publishers","host_organization_lineage":["https://openalex.org/P4322632785"],"host_organization_lineage_names":["Viguera Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revista de Neurolog\u00eda","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024126803","display_name":"Adnan Tanov\u00edc","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Adnan Tanovic","raw_affiliation_strings":["Facultat de Biologia, Universitat de Barcelona, Avda. Diagonal 645, E-08028 Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Facultat de Biologia, Universitat de Barcelona, Avda. Diagonal 645, E-08028 Barcelona, Spain","institution_ids":["https://openalex.org/I71999127"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048398150","display_name":"Vicente Alfaro","orcid":"https://orcid.org/0000-0002-0150-2390","observed_orcids":["https://orcid.org/0000-0002-0150-2390"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vicente Alfaro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.813,"has_fulltext":false,"cited_by_count":31,"citation_normalized_percentile":{"value":0.63665835,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"42","issue":"10","first_page":"607","last_page":"607"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.8485999703407288,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.8485999703407288,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.11069999635219574,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.019500000402331352,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/memantine","display_name":"memantine","score":1.0},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.8019999861717224},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.8230000138282776},{"id":"https://openalex.org/keywords/vascular-dementia","display_name":"vascular dementia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/excitotoxicity","display_name":"excitotoxicity","score":0.902999997138977},{"id":"https://openalex.org/keywords/glutamate-excitotoxicity","display_name":"glutamate excitotoxicity","score":0.8130000233650208},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9869999885559082},{"id":"https://openalex.org/keywords/amyloid-beta","display_name":"amyloid-beta","score":0.824999988079071},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.9179999828338623},{"id":"https://openalex.org/keywords/cognitive-enhancement","display_name":"cognitive enhancement","score":0.5659999847412109},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.7319999933242798}],"concepts":[{"id":"https://openalex.org/C2779484449","wikidata":"https://www.wikidata.org/wiki/Q412189","display_name":"Memantine","level":4,"score":0.9389166831970215},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.8375426530838013},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.7729116678237915},{"id":"https://openalex.org/C2781012912","wikidata":"https://www.wikidata.org/wiki/Q901117","display_name":"Excitotoxicity","level":4,"score":0.6807227730751038},{"id":"https://openalex.org/C2777952318","wikidata":"https://www.wikidata.org/wiki/Q583908","display_name":"Vascular dementia","level":4,"score":0.5843874216079712},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.577238917350769},{"id":"https://openalex.org/C2780648746","wikidata":"https://www.wikidata.org/wiki/Q28208871","display_name":"Glutamatergic","level":4,"score":0.48298659920692444},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4688217341899872},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3993600010871887},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3786998391151428},{"id":"https://openalex.org/C2779483572","wikidata":"https://www.wikidata.org/wiki/Q83030","display_name":"Dementia","level":3,"score":0.35369980335235596},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.2492923140525818},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.23827055096626282},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.22438392043113708},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.18438485264778137}],"mesh":[{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008559","descriptor_name":"Memantine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016194","descriptor_name":"Receptors, N-Methyl-D-Aspartate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018698","descriptor_name":"Glutamic Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.33588/rn.4210.2005252","doi":"https://doi.org/10.33588/rn.4210.2005252","is_oa":false,"landing_page_url":"https://doi.org/10.33588/rn.4210.2005252","pdf_url":null,"source":{"id":"https://openalex.org/S184263677","display_name":"Revista de Neurolog\u00eda","issn_l":"0210-0010","issn":["0210-0010","1576-6578"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4322632785","host_organization_name":"Viguera Publishers","host_organization_lineage":["https://openalex.org/P4322632785"],"host_organization_lineage_names":["Viguera Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revista de Neurolog\u00eda","raw_type":"journal-article"},{"id":"pmid:16703529","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16703529","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Revista de neurologia","raw_type":"English Abstract"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9476000070571899,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2140959932","https://openalex.org/W2012871147","https://openalex.org/W4243873633","https://openalex.org/W1730334876","https://openalex.org/W2081505844","https://openalex.org/W2001604134","https://openalex.org/W1997411557","https://openalex.org/W2117396078","https://openalex.org/W1973715378","https://openalex.org/W1974269419"],"abstract_inverted_index":{"AIM:":[0],"To":[1],"review":[2],"the":[3,20,65,70,84,146,149],"therapeutic":[4],"efficacy":[5,161],"of":[6,11,27,40,83,91,103,152,165,176],"memantine,":[7],"an":[8,50],"uncompetitive":[9,101],"antagonist":[10,102],"N-methyl-D-aspartate":[12],"(NMDA)-glutamate":[13],"receptor.":[14],"DEVELOPMENT:":[15],"Alzheimer's":[16],"disease":[17],"(AD)":[18],"is":[19,57,87,115],"most":[21],"common":[22,89],"neurodegenerative":[23,94],"disorder":[24],"and":[25,43,55,120,162,178],"cause":[26],"dementia":[28],"with":[29,69,111,118,127],"ageing":[30],"worldwide.":[31],"The":[32,75,160],"main":[33],"AD":[34,177],"symptoms":[35],"are":[36],"a":[37,44,88,98,116],"gradual":[38],"loss":[39],"cognitive":[41],"function":[42],"functional":[45],"impairment.":[46],"Glutamatergic":[47],"excitatory":[48],"neurotransmission,":[49],"important":[51],"process":[52],"in":[53,60,109,144,170],"learning":[54],"memory,":[56],"severely":[58],"disrupted":[59],"AD,":[61,139],"probably":[62],"due":[63],"to":[64],"oxidative":[66],"stress":[67],"associated":[68],"beta-amyloid":[71],"peptide":[72],"(1-42)":[73],"increase.":[74],"glutamate-related":[76],"excitotoxicity,":[77],"mainly":[78],"mediated":[79],"by":[80],"NMDA":[81,104],"subtype":[82],"glutamate":[85],"receptors,":[86],"clue":[90],"pathogenesis":[92],"for":[93,130,174],"disorders.":[95],"CONCLUSIONS:":[96],"Memantine,":[97],"moderate-affinity,":[99],"voltage-dependent,":[100],"receptor,":[105],"shows":[106],"neuroprotective":[107,119],"effects":[108],"patients":[110],"moderate-to-severe":[112],"AD.":[113,131],"Memantine":[114],"drug":[117],"cognition-enhanced":[121],"properties,":[122],"which":[123],"can":[124],"be":[125],"combined":[126],"other":[128],"treatments":[129],"Thus,":[132],"memantine":[133,166],"does":[134],"not":[135],"stop":[136],"or":[137],"reverse":[138],"but":[140],"its":[141],"moderating":[142],"effect":[143],"protecting":[145],"brain":[147,158],"from":[148],"toxic":[150],"levels":[151],"calcium,":[153],"allows":[154],"normal":[155],"signaling":[156],"among":[157],"neurons.":[159],"safety":[163],"profile":[164],"have":[167],"been":[168],"reported":[169],"several":[171],"clinical":[172],"trials":[173],"treatment":[175],"vascular":[179],"dementia.":[180]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}